| Full Name | Yanjin Yang |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 506 6th St, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003155730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 285917 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Girling Health Care Of New York | Brooklyn, NY | Home health agency |
| New York-presbyterian Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Physician Services Pc | 0547579427 | 481 |
News Archive
Daniel Herman, MD, PhD presented a research abstract at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL indicating that the rates of concussions and musculoskeletal injuries may have increased with the use of protective headgear in High School Girls Lacrosse.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
"Far too often we are seeing national governments overreact to market fluctuations to the extent that they are making pledges about and taking measures toward food self-sufficiency," Emery Koenig, executive vice president and chief risk officer of Cargill, writes in the Chicago Council on Global Affairs' "Global Food For Thought" blog.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
› Verified 8 days ago
| Entity Name | Park Slope Medicine, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770534984 PECOS PAC ID: 7810809936 Enrollment ID: O20031105000595 |
News Archive
Daniel Herman, MD, PhD presented a research abstract at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL indicating that the rates of concussions and musculoskeletal injuries may have increased with the use of protective headgear in High School Girls Lacrosse.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
"Far too often we are seeing national governments overreact to market fluctuations to the extent that they are making pledges about and taking measures toward food self-sufficiency," Emery Koenig, executive vice president and chief risk officer of Cargill, writes in the Chicago Council on Global Affairs' "Global Food For Thought" blog.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
› Verified 8 days ago
| Entity Name | Kings Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083045090 PECOS PAC ID: 0547579427 Enrollment ID: O20151015000175 |
News Archive
Daniel Herman, MD, PhD presented a research abstract at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL indicating that the rates of concussions and musculoskeletal injuries may have increased with the use of protective headgear in High School Girls Lacrosse.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
"Far too often we are seeing national governments overreact to market fluctuations to the extent that they are making pledges about and taking measures toward food self-sufficiency," Emery Koenig, executive vice president and chief risk officer of Cargill, writes in the Chicago Council on Global Affairs' "Global Food For Thought" blog.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yanjin Yang, 506 6th St, Brooklyn, NY 11215-3609 Ph: (718) 780-3000 | Yanjin Yang, 506 6th St, Brooklyn, NY 11215-3609 Ph: (718) 780-3000 |
News Archive
Daniel Herman, MD, PhD presented a research abstract at the 27th Annual Meeting of the American Medical Society for Sports Medicine in Lake Buena Vista, FL indicating that the rates of concussions and musculoskeletal injuries may have increased with the use of protective headgear in High School Girls Lacrosse.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
BioCryst Pharmaceuticals, Inc. announced favorable 52-week safety results and sustained efficacy from the extension phase of its randomized Phase 2b trial of ulodesine (BCX4208) added to allopurinol in patients with gout who had failed to reach the serum uric acid (sUA) therapeutic goal of <6 mg/dL on allopurinol alone, as well as positive Phase 2 safety results in patients with mild to moderate renal impairment.
"Far too often we are seeing national governments overreact to market fluctuations to the extent that they are making pledges about and taking measures toward food self-sufficiency," Emery Koenig, executive vice president and chief risk officer of Cargill, writes in the Chicago Council on Global Affairs' "Global Food For Thought" blog.
Medications or biologic agents that target T-cells, white blood cells involved in the body's immune system, appear to offer significant benefit to patients suffering from psoriatic arthritis (PsA), a type of arthritis that affects up to 48 percent of patients with the skin disease psoriasis, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons.
› Verified 8 days ago
Dr. Alexander Usorov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Ashwad Afzal, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |